CureDuchenne Ventures' $1M Investment in Entos Pharmaceuticals for Innovative Gene Therapy#USA#San_Antonio#CureDuchenne#Entos_Pharmaceuticals#Fusogenix_PLV
CureDuchenne Ventures' $1M Investment in Entos Pharmaceuticals for Innovative Gene Therapy
CureDuchenne Ventures has made a significant $1M investment in Entos Pharmaceuticals. This funding aims to advance the development of gene therapies for Duchenne muscular dystrophy.
third-news.com
May 22, 2025 at 12:33 PM
CureDuchenne Ventures' $1M Investment in Entos Pharmaceuticals for Innovative Gene Therapy#USA#San_Antonio#CureDuchenne#Entos_Pharmaceuticals#Fusogenix_PLV